Goat anti-Human IgG (Kappa light chain) (A56854)
Human Ig Kappa Light Chain Antibody MAB10050-100: R&D Systems
LaboShop | Products | Thermo Scientific™ CaptureSelect™ LC-kappa (mur) Affinity Matrix, 10 ML
Goat anti-Human Kappa Light Chain Cross-Adsorbed (A18861)
CaptureSelect Affinity Ligands for Antibody Detection and ... - ForteBio
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
Human Ig Kappa Light Chain Antibody MAB100501-100: R&D Systems
CaptureSelect™ KappaXL PhyTip columns for purification of human IgGs
Deduced amino acid sequences of the variable heavy and light chain... | Download Scientific Diagram
Bispecific Antibodies: Downstream Purification - BioProcess InternationalBioProcess International
Frontiers | Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening
CaptureSelect™ Kappa Select Leakage ELISA
CaptureSelect™ LC-kappa (mur) Affinity Matrix
Immunoglobulin light chain - Wikipedia
Frontiers | Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies
LaboShop | Products | Thermo Scientific™ CaptureSelect™ Human Fab-kappa Kinetics Biotin Conjugate, 500 µg
Human Ig Kappa Light Chain Antibody MAB100501-100: R&D Systems
Capture of bispecific antibodies and removal of product-related impurities | Cytiva
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG | Nature Communications
Purification of Antibodies and Antibody Fragments Using CaptureSelect™ Affinity Resins | SpringerLink
Antibodies | Free Full-Text | Antibody Fragments and Their Purification by Protein L Affinity Chromatography
Antibody homotypic interactions are encoded by germline light chain complementarity determining region 2 | PNAS
Human Ig Kappa Light Chain Antibody MAB100501-100: R&D Systems
Mouse anti-Human Kappa Light Chain, Biotin (MA5-12114)
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
